ezogabine has been researched along with amantadine in 1 studies
| Studies (ezogabine) | Trials (ezogabine) | Recent Studies (post-2010) (ezogabine) | Studies (amantadine) | Trials (amantadine) | Recent Studies (post-2010) (amantadine) |
|---|---|---|---|---|---|
| 383 | 26 | 241 | 4,110 | 515 | 753 |
| Protein | Taxonomy | ezogabine (IC50) | amantadine (IC50) |
|---|---|---|---|
| Matrix protein 2 | Influenza A virus (A/udorn/1972(H3N2)) | 4.7 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hamann, M; Lange, N; Lemm, C; Richter, A; Sander, SE | 1 |
1 other study(ies) available for ezogabine and amantadine
| Article | Year |
|---|---|
Retigabine, a K(V)7 (KCNQ) potassium channel opener, attenuates L-DOPA-induced dyskinesias in 6-OHDA-lesioned rats.
Topics: Amantadine; Aminopyridines; Animals; Anticonvulsants; Antiparkinson Agents; Behavior, Animal; Carbamates; Dyskinesia, Drug-Induced; Female; Motor Activity; Oxidopamine; Phenylenediamines; Rats; Rats, Sprague-Dawley; Stereotyped Behavior | 2012 |